DEAR1 maps within one of the most frequent regions of LOH in breast cancers with poor prognosis in node negative breast cancers as well as a genomic interval associated with LOH in many histologically diverse epithelial cancers, suggesting that it could be a candidate tumor suppressor in the region [25]–[28]. This evidence concerns the gene TRIM62 and neoplasm.